{"id":"https://openalex.org/W2603065898","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8529","title":"Idelalisib efficacy and safety in follicular lymphoma patients from a phase 2 study.","display_name":"Idelalisib efficacy and safety in follicular lymphoma patients from a phase 2 study.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2603065898","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8529","mag":"2603065898"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.8529","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8529","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.8529","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086354986","display_name":"Gilles A. Salles","orcid":"https://orcid.org/0000-0002-9541-8666","observed_orcids":["https://orcid.org/0000-0002-9541-8666"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles A. Salles","raw_affiliation_strings":["Hospices Civils de Lyon, Universit\u00e9 Claude Bernard, Pierre B\u00e9nite, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospices Civils de Lyon, Universit\u00e9 Claude Bernard, Pierre B\u00e9nite, France","institution_ids":["https://openalex.org/I4210100596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080630441","display_name":"Stephen J. Schuster","orcid":"https://orcid.org/0000-0002-3376-8978","observed_orcids":["https://orcid.org/0000-0002-3376-8978"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen J Schuster","raw_affiliation_strings":["Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081213752","display_name":"Sven de Vos","orcid":"https://orcid.org/0000-0002-6715-4851","observed_orcids":["https://orcid.org/0000-0002-6715-4851"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sven De Vos","raw_affiliation_strings":["Department of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015361329","display_name":"Nina D. Wagner\u2010Johnston","orcid":"https://orcid.org/0000-0001-6529-9793","observed_orcids":["https://orcid.org/0000-0001-6529-9793"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina D. Wagner-Johnston","raw_affiliation_strings":["Department of Medicine, Washington University School of Medicine, St Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Washington University School of Medicine, St Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067716137","display_name":"Andreas Viardot","orcid":"https://orcid.org/0000-0001-9593-6327","observed_orcids":["https://orcid.org/0000-0001-9593-6327"]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Viardot","raw_affiliation_strings":["Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082892912","display_name":"Christopher R. Flowers","orcid":"https://orcid.org/0000-0002-9524-3990","observed_orcids":["https://orcid.org/0000-0002-9524-3990"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Flowers","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104035851","display_name":"Matthias Will","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthias Will","raw_affiliation_strings":["Gilead Sciences, Inc., Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025092706","display_name":"Madlaina Breuleux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madlaina Breuleux","raw_affiliation_strings":["Gilead Sciences, Inc., Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027453053","display_name":"Wayne Russell Godfrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne Russell Godfrey","raw_affiliation_strings":["Gilead Sciences, Inc., Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085791499","display_name":"Bess E. Sorensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bess Sorensen","raw_affiliation_strings":["Gilead Sciences, Inc., Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay Gopal","raw_affiliation_strings":["Medical Oncology Division, University of Washington School of Medicine, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Division, University of Washington School of Medicine, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"8529","last_page":"8529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.025800000876188278,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idelalisib","display_name":"idelalisib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.9440000057220459},{"id":"https://openalex.org/keywords/indolent-non-hodgkin-lymphoma","display_name":"indolent non-Hodgkin lymphoma","score":0.9210000038146973},{"id":"https://openalex.org/keywords/rituximab-refractory-disease","display_name":"rituximab-refractory disease","score":0.8109999895095825},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.902999997138977},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9900000095367432},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5339999794960022},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.35199999809265137},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6690000295639038},{"id":"https://openalex.org/keywords/bulky-disease","display_name":"bulky disease","score":0.8870000243186951},{"id":"https://openalex.org/keywords/time-to-response","display_name":"time to response","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9326250553131104},{"id":"https://openalex.org/C2779260929","wikidata":"https://www.wikidata.org/wiki/Q5908266","display_name":"Idelalisib","level":5,"score":0.8404703140258789},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8230805397033691},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7602237462997437},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5833027958869934},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5705311298370361},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.5700356960296631},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5474619269371033},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5150556564331055},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5034202933311462},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.44186750054359436},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4418322443962097},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3788753151893616},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36979925632476807},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3125509023666382},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.2511720657348633},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.19892963767051697},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.15632200241088867},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.8529","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8529","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.8529","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2983804219","https://openalex.org/W3211840167","https://openalex.org/W3097180139","https://openalex.org/W4210679538","https://openalex.org/W2984588184","https://openalex.org/W4293102195","https://openalex.org/W2565499703","https://openalex.org/W2530975479","https://openalex.org/W2969570671","https://openalex.org/W2589729991"],"abstract_inverted_index":{"8529":[0],"Background:":[1],"There":[2],"is":[3],"an":[4,53,111],"unmet":[5],"need":[6],"for":[7,14],"new":[8],"treatment":[9,177,188,205,340],"options":[10],"in":[11,36,43,65,104,210,249,332],"FL,":[12],"particularly":[13],"heavily":[15],"pretreated,":[16],"high-risk":[17,140],"patients":[18,73,91,186,250,337],"refractory":[19,48,72,164],"to":[20,49,165,170,235],"anti-CD20":[21],"and":[22,31,52,63,147,226,253,277,283,301,314,321,329],"chemotherapy.":[23],"Idelalisib,":[24],"a":[25,37,139],"PI3K\u03b4":[26],"inhibitor,":[27],"showed":[28],"antitumor":[29],"activity":[30],"acceptable":[32,330],"tolerability":[33],"as":[34],"monotherapy":[35],"pivotal":[38],"phase":[39],"2,":[40,96],"open-label":[41],"study":[42,129],"indolent":[44],"non-Hodgkin":[45],"lymphoma":[46],"(iNHL)":[47],"rituximab":[50],"(R)":[51],"alkylating":[54],"agent":[55],"(NCT01282424).":[56],"This":[57],"post":[58],"hoc":[59],"analysis":[60],"evaluated":[61,109],"efficacy":[62],"safety":[64,331],"the":[66,122,262],"FL":[67,93,150,336],"patient":[68],"subset.":[69],"Methods:":[70],"Double":[71],"with":[74,92,183,251,338],"histologically":[75],"confirmed":[76],"iNHL":[77],"received":[78],"oral":[79],"idelalisib":[80],"150":[81],"mg":[82],"BID":[83],"until":[84],"disease":[85],"progression":[86],"(PD)":[87],"or":[88,97],"unacceptable":[89],"tolerability;":[90],"(grade":[94],"1,":[95,275],"3a;":[98],"n":[99],"=":[100],"72)":[101],"were":[102,108,163,292,316],"included":[103],"this":[105],"analysis.":[106],"Responses":[107],"by":[110,206],"independent":[112],"review":[113],"committee":[114],"using":[115],"standardized":[116],"criteria.":[117],"The":[118,212],"primary":[119],"endpoint":[120],"was":[121,134,159,179,216,237,244,256,269,280],"overall":[123,266],"response":[124,236,242],"rate":[125],"(ORR).":[126],"Results:":[127],"At":[128,172],"entry,":[130],"patients\u2019":[131],"median":[132,175,232,241],"age":[133],"62":[135],"y,":[136],"54%":[137],"had":[138,144,149],"FLIPI":[141],"score,":[142],"22%":[143],"bulky":[145],"disease,":[146],"17%":[148],"grade":[151,306],"3a.":[152],"Median":[153,265],"(range)":[154,176,233],"number":[155],"of":[156,305],"prior":[157],"treatments":[158],"4":[160],"(2\u201312);":[161],"86%":[162],"their":[166],"last":[167,263],"therapy":[168],"(32/50":[169],"bendamustine).":[171],"data":[173],"cutoff,":[174],"duration":[178,243],"6.5":[180],"(0.6\u201331.0)":[181],"mo,":[182,240,258],"65":[184],"(90%)":[185],"off":[187],"(PD,":[189],"38;":[190],"adverse":[191],"events":[192],"[AEs],":[193],"15;":[194],"investigator":[195],"decision,":[196],"7;":[197],"death,":[198],"5).":[199],"Lymph":[200],"node":[201],"size":[202],"decreased":[203],"during":[204],"\u2265":[207,289,307],"50%":[208],"SPD":[209],"57%.":[211],"ORR":[213],"(95%":[214],"CI)":[215],"56%":[217],"(43\u201367;":[218],"P<":[219],"0.001),":[220],"including":[221],"10":[222],"complete":[223],"responses":[224,328],"(CR)":[225],"30":[227],"partial":[228],"responses.":[229],"Kaplan-Meier":[230],"(KM)\u2014estimated":[231],"time":[234],"2.6":[238],"(1.6\u201311.0)":[239],"11":[245,257],"mo":[246,248],"(27":[247],"CR),":[252],"progression-free":[254],"survival":[255,267],"substantially":[259],"longer":[260],"vs":[261],"regimen.":[264],"(OS)":[268],"not":[270],"reached;":[271],"KM-estimated":[272],"OS":[273],"at":[274],"1.5,":[276],"2":[278],"y":[279],"87%,":[281],"74%,":[282],"68%.The":[284],"most":[285],"common":[286],"AEs":[287],"(any/grade":[288],"3,":[290],"%)":[291],"diarrhea":[293],"(51/14),":[294],"cough":[295],"(32/0),":[296],"pyrexia":[297],"(29/4),":[298],"fatigue":[299],"(28/0),":[300],"nausea":[302],"(28/3).":[303],"Rates":[304],"3":[308],"transaminase":[309],"elevation,":[310],"pneumonitis,":[311],"neutropenia,":[312],"anemia,":[313],"thrombocytopenia":[315],"14%,":[317],"4%,":[318],"22%,":[319],"3%,":[320],"6%.":[322],"Conclusions:":[323],"Idelalisib":[324],"demonstrated":[325],"rapid,":[326],"durable":[327],"highly":[333],"refractory,":[334],"relapsed":[335],"limited":[339],"options.":[341],"Clinical":[342],"trial":[343],"information:":[344],"NCT01282424.":[345]},"counts_by_year":[{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2017-04-07T00:00:00"}